The Value of Molecular Response in Chronic Myeloid Leukemia: The Present and the Future

QR Code

The Value of Molecular Response in Chronic Myeloid Leukemia: The Present and the Future

None

Saved in:

Bibliographic Details
Main Authors:	Falchi, Lorenzo, Appolloni, Viviana, Ferranti, Lucia, Liberati, Anna Marina
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/25653
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New Molecular Markers in Acute Myeloid Leukemia
by: Iñigo, Silvia de la Iglesia, et al.
Published: (2011)

Molecular genetics monitoring of tyrosine kinase inhibitor therapy for chronic myeloid leukemia
by: S. I. Kutsev, et al.
Published: (2022-11-01)

ACUTE MYELOID LEUKEMIA PRESENTING AS ISOLATED MYELOID SARCOMA: A CASE REPORT
by: Elif Canpolat Hırfanoğlu, et al.
Published: (2025-07-01)

Chronic myeloid leukemia in a patient with beta thalassemia major: a rare presentation
by: Alyna Hafeez, et al.
Published: (2025-07-01)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Use of dasatinib in chronic myeloid leukemia therapy
by: O. Yu. Vinogradova, et al.
Published: (2008-12-01)

Cytokine profile in patients with chronic myeloid leukemia
by: T. N. Aleksandrova, et al.
Published: (2024-01-01)

Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2020-12-01)

Priapismus as Leukostasis Manifestation in Chronic Myeloid Leukemia
by: Wulyo Rajabto, et al.
Published: (2020-12-01)

MOLECULAR BIOLOGY AND DRUG THERAPIES OF CHRONIC MYELOID LEUKEMIA: A REVIEW OF RECENT LITERATURE
by: Sameen Shahid, et al.
Published: (2024-03-01)

PATHOMORPHOLOGICAL ANALYSIS OF TREPANOBIOPTATES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOCYTIC LEUKEMIA: ASSESSMENT OF THE PROGNOSTIC VALUE OF MYELOFIBROSIS WHEN COMPARED WITH CLINICAL DATA
by: T. Y. Dolgikh, et al.
Published: (2019-02-01)

The Proteasome as a Therapeutic Target in Chronic Myeloid Leukemia
by: Pérez-Roger, Ignacio, et al.
Published: (2011)

CLINICAL AND PATHOMORPHOLOGICAL EXAMINATION OF MYELOFIBROSIS IN CHRONIC MYELOID LEUKEMIA
by: T. Yu. Dolgikh, et al.
Published: (2016-02-01)

TELOMERES AND TELOMERASE ACTIVITY IN CHRONIC MYELOID LEUKEMIA (REVIEW)
by: A. S. Lyamkina, et al.
Published: (2019-03-01)

PECULIARITIES OF CHRONIC MYELOID LEUKEMIA INCIDENCE IN THE ALTAi krai
by: O. V. Efremova, et al.
Published: (2019-05-01)

Metabolomic Profiling and Bioanalysis of Chronic Myeloid Leukemia: Identifying Biomarkers for Treatment Response and Disease Monitoring
by: Selim Sayın, et al.
Published: (2025-06-01)

Transformation of Chronic Myeloid Leukemia to Acute Undifferentiated Leukemia: Case Report and Literature Review
by: Oussama Grari, et al.
Published: (2025-04-01)

Key principles of drug therapy in patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2023-07-01)

Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
by: Takahashi, Naoto, et al.
Published: (2012)

Chronic myeloid leukemia — before and after imatinib (part II)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (Third part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Chronic myeloid leukemia — before and after imatinib (First part)
by: E. G. Lomaia, et al.
Published: (2022-11-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
by: A. K. Golenkov, et al.
Published: (2014-07-01)

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01)

CHRONIC MYELOID LEUKEMIA - CLINICAL AND IMMUNOLOGICAL PECULIARITIES IN ADULT PATIENTS
by: O. V. Smirnova
Published: (2012-05-01)

Dose Optimization of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
by: Chen J, et al.
Published: (2025-07-01)

Bosutinib for Successful Treatment‐Free Remission in Chronic Myeloid Leukemia
by: Yuki Fujioka, et al.
Published: (2025-05-01)

COVID-19 PANDEMIC AND CHRONIC MYELOID LEUKEMIA: A REVIEW
by: Hafiza Sidra Bashir, et al.
Published: (2022-10-01)

Myeloid Leukemia: A Molecular Focus on Etiology and Risk Within Africa
by: Ibrahim, Muntaser E., et al.
Published: (2011)

PROGNOSTIC VALUE OF CD56 EXPRESSION IN CHILDREN WITH ACUTE MYELOID LEUKEMIA
by: Reyhan Aliyeva, et al.
Published: (2025-07-01)

Acute Myeloid Leukemia With NPM1 Mutation Presenting With Rapidly Progressing Hypereosinophilia
by: S. Einarsdottir, et al.
Published: (2025-01-01)

Therapy of Acute Myeloid Leukemia
by: El-Cheikh, Jean, et al.
Published: (2012)

Pediatric Acute Myeloid Leukemia
by: Zwaan, C. Michel, et al.
Published: (2011)

Results of various somatic mutations detection in patients with chronic myeloid leukemia
by: E. A. Kuzmina, et al.
Published: (2024-12-01)

Treatment-free remission in patients with chronic myeloid leukemia: literature review
by: A. N. Petrova, et al.
Published: (2019-10-01)

CHRONIC MYELOID LEUKEMIA: EPIDEMIOLOGY AND FIFTEENTH YEARS OF THERAPY IN THE NOVOSIBIRSK REGION
by: A. S. Lyamkina, et al.
Published: (2020-03-01)

Stability and Bifurcation of the Immune Model of Chronic Myeloid Leukemia with Time Delay
by: WANG Jingnan, et al.
Published: (2024-10-01)

Molecular Markers for Risk Stratification in Adult Acute Myeloid Leukemia with Normal Cytogenetics
by: Fuchs, Ota
Published: (2011)

DNA Repair in Acute Myeloid Leukemia and Myelodysplastic Syndromes
by: Szmigielska-Kaplon, Anna, et al.
Published: (2011)